[Treatment of recurrent spontaneous abortion associated with the antiphospholipid antibody syndrome].
Treatment of repeated foetal loss associated with antiphospholipid syndrome was initially based on immunomodulating therapy such as corticosteroids or intravenous immunoglobulins. More recently aspirin and heparin have been assessed because of the thrombotic mechanisms involved in foetal losses. Randomized controlled trials have demonstrated that the association of aspirin and heparin is superior to aspirin alone in the prevention of recurrence of pregnancy loss.
D000026:Abortion, Habitual / Q000276:immunology* / Q000517:prevention & control*; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications*; D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D011247:Pregnancy
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D006493:Heparin; D001241:Aspirin